etoposide has been researched along with Hand-Foot Syndrome in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (66.67) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Chen, CK; Hayashi, S; Ikari, K; Kusano, J; Ogai, A; Ozawa, Y; Yamamoto, R; Yoshida, R | 1 |
Camilleri, MJ; Podjasek, JO | 1 |
Bozkurt, C; Dogru, M; Kocaoglu, AC; Ozmen, S | 1 |
1 trial(s) available for etoposide and Hand-Foot Syndrome
Article | Year |
---|---|
Bullous acral erythema: an additional consideration in the differential diagnosis of pauci-inflammatory subepidermal bullae*.
Topics: Antineoplastic Combined Chemotherapy Protocols; Bleomycin; Blister; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hand-Foot Syndrome; Humans; Lymphoma, Large B-Cell, Diffuse; Methotrexate; Middle Aged; Prednisolone; Vincristine | 2012 |
2 other study(ies) available for etoposide and Hand-Foot Syndrome
Article | Year |
---|---|
[A Case of Adult T-Cell Leukemia/Lymphoma with Severe Hand-Foot Syndrome during Administration of Modified LSG15 Regimen].
Topics: Adult; Antineoplastic Combined Chemotherapy Protocols; Carboplatin; Cyclophosphamide; Doxorubicin; Etoposide; Female; Hand-Foot Syndrome; Humans; Leukemia-Lymphoma, Adult T-Cell; Lymphoma; Middle Aged; Nitrosourea Compounds; Prednisolone; Vincristine; Vindesine | 2020 |
Probable cytarabine-induced acral erythema: report of 2 pediatric cases.
Topics: Adolescent; Antineoplastic Combined Chemotherapy Protocols; Child, Preschool; Cytarabine; Etoposide; Female; Hand-Foot Syndrome; Humans; Leukemia, Myeloid, Acute; Mitoxantrone; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prognosis | 2013 |